The European Medicines Agency is taking steps to rethink how certain high-need medicines reach patients, with a new concept paper...
A study from the RAND Corporation has revealed a significant gap between the growing political momentum for psychedelic reform and actual US public opinion.
This article was written by Dr.
One of Britain’s central think tanks for drug policy reform is looking for new partners to join forces in 2026.
A new study investigates how so-called “self-transcendent” psychedelic states can trigger enduring changes in meaning-making, values, and perceptions of reality.
This article was submitted by by Dr Shoona Vincent, Vice President of Clinical Science at MAC Clinical Research, as part of Psychedelic Health’s op-ed program.
In 2025, the psychedelic medicine sector reached a more defined phase of maturity, as Big Pharma entry, late-stage clinical readouts, and incremental regulatory shifts began to...
This article was made possible thanks to on-site reporting by Sasha Mbilika.
Psilocybin continues to gain momentum as a possible alternative to mental health treatments that leave large numbers of patients without recovery.
Compass Pathways is one of the companies spearheading clinical development of synthetic psilocybin, the compound naturally found in psilocybin mushrooms.
